ANI Pharmaceuticals (ANIP)

[Just the facts maam]

Jp2011, according to ANIP's last Corporate Presentation Acth category has grown 13 consecutive month. If this trend continues, it look like ANIP is capturing the majority of the growth. Obviously this is just a guess, but I believe we will see between $27 and $30 million in Corti sales. maybe more if the pulmonary sales started kicking it up a notch.